Holen Sie sich die Stockscreener-App
1.14
3.39%
-0.04
Handel nachbörslich:
1.16
0.02
+1.75%
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
18.33%
0.098
|
0.12 | 0.168 | 0.366 | 0.214 |
| Cost Of Revenue |
89.72%
0.011
|
0.107 | 0.014 | 0.832 | 1.17 |
| Gross Profit |
569.23%
0.087
|
0.013 | 0.154 | -0.466 | -0.956 |
Operating Expenses
|
9.77%
14.31
|
15.87 | 10.25 | 10.03 | 14.34 |
| Benefits Costs and Expenses |
10.31%
14.33
|
15.97 | 7.422 | 11.22 | 15.51 |
| Costs And Expenses |
10.31%
14.33
|
15.97 | 10.27 | 10.86 | 15.51 |
| Operating Income/Loss |
10.24%
-14.23
|
-15.85 | -10.10 | -10.49 | -15.29 |
| Income/Loss From Continuing Operations Before Tax |
25.85%
-14.23
|
-19.19 | -7.254 | -10.86 | -15.29 |
| Income/Loss From Continuing Operations After Tax |
61.10%
-30.91
|
-19.19 | -7.254 | -10.86 | -13.65 |
|
Net Income/Loss
|
61.10%
-30.91
|
-19.19 | -7.254 | -10.86 | -13.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
81.00%
14.20
|
7.843 | 4.834 | -35.32 | 42.39 |
| Diluted Average Shares |
81.00%
14.20
|
7.843 | 4.834 | -35.32 | 42.39 |
| Basic Earnings Per Share |
11.02%
-2.18
|
-2.45 | -1.50 | -22.22 | -0.32 |
| Diluted Earnings Per Share |
11.02%
-2.18
|
-2.45 | -1.50 | -22.22 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):